September 22, 2020

AstraZeneca-Oxford vaccine reports 2nd serious adverse event, now what?

#PureScience #Covid19 The AstraZeneca-Oxford vaccine has now had two participants report rare neurological reactions in a span of two months. ThePrint’s Sandhya Ramesh takes a look at these concerning findings and the implications for the viability fo the vaccine. --------------------------------------------------------------------------------------------- AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints https://www.nytimes.com/2020/09/19/health/astrazeneca-vaccine-safety-blueprints.html?smid=tw-share --------------------------------------------------------------------------------------------- Participant information sheet: https://covid19vaccinetrial.co.uk/files/cov002pisages18-55yearsv11011sept2020pdf --------------------------------------------------------------------------------------------- AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K. https://www.statnews.com/2020/09/08/astrazeneca-covid-19-vaccine-study-put-on-hold-due-to-suspected-adverse-reaction-in-participant-in-the-u-k/ ------------------------------------------------------------------------------------------------------------------------------------------------------------------

More episodes

Load more

Play this podcast on Podbean App